Mounjaro®
Starting from £179.99/mo
Start journey Learn moreClinical trial data show that tirzepatide produces substantial average weight reduction, and a lighter body places measurably less demand on the heart and joints during movement — so it is not surprising that many people report noticing real differences in how exercise feels once treatment is under way. The effect Mounjaro has on fitness is not a direct pharmacological boost; it works indirectly, through changes in body composition, appetite, and energy availability. As a prescription-only medicine, Mounjaro is assessed and prescribed by a registered clinician based on your individual health picture, and what you experience during treatment depends on a number of factors beyond the medicine itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults with obesity through 72 weeks of tirzepatide treatment. At the highest dose, average body-weight reduction reached around 20–21%. That scale of change matters for fitness in a concrete, mechanical way: carrying substantially less weight across every movement reduces the energy cost of exercise, lowers peak joint loading, and can bring aerobic activity that once felt impossible back into reach.
What the trials do not show is a direct drug-on-muscle or drug-on-cardiovascular-fitness effect. Mounjaro is a dual GIP and GLP-1 receptor agonist, it works on appetite regulation and blood-sugar control, not on muscle fibres or aerobic capacity. If you want to understand what the mounjaro effect actually involves, the fitness benefits people notice are downstream of the weight loss itself, rather than a direct action on physical capacity. That distinction is worth sitting with: the medicine creates the conditions for improved fitness; the work of building it still belongs to movement and habit.
A second factor is body composition. Weight loss from any intervention can include lean muscle mass alongside fat. The research suggests that the proportion of lean mass lost is broadly in line with other effective weight-loss approaches, but it is not zero. This is why clinical guidance on GLP-1 treatment consistently emphasises resistance exercise and sufficient dietary protein, not as optional extras, but as the practical tools that help tip that balance towards fat.
A question our prescribers hear regularly is why someone who expected to feel more energetic feels, at first, noticeably tired. Fatigue is a recognised side effect of tirzepatide, noted in the NHS medicines information for tirzepatide, and it tends to be most pronounced in two windows: the first few weeks of starting treatment, and the days following a dose increase.
The likely explanation is physiological adjustment. Calorie intake drops, often sharply, as appetite suppression takes hold. The body is re-calibrating its fuel use. For many people, this means that gym sessions feel harder than usual, motivation dips, and effort that was routine starts to feel effortful. Most people find this settles within days to around two weeks as the body adapts, though everyone's experience varies.
Pacing yourself during this window matters. A short walk maintained through a difficult week is better for long-term progress than an abandoned training plan. The NHS guidance on healthy weight and activity emphasises sustainable increases in movement rather than acute intensity, sensible advice at any stage, and particularly relevant here.
Dehydration from nausea or reduced eating can amplify fatigue too. Keeping fluid intake consistent, even when appetite for food is low, is a practical detail worth not overlooking.
The clinical picture points clearly in one direction: people who combine pharmacological weight management with regular physical activity, particularly resistance training, tend to preserve more lean mass and report better functional outcomes than those who rely on the medicine alone. This is consistent across the GLP-1 evidence base, and it is reflected in the licensed indication itself, Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone intervention.
Practically, that means starting or returning to exercise does not need to wait for significant weight loss. Even modest activity during the early months, walking, swimming, bodyweight work, contributes. The goal during active treatment is not peak performance but keeping the musculoskeletal system engaged so that, as weight comes down, there is a functional base to build on.
If you are thinking about cost and what structured support around treatment looks like, understanding what a legitimate private prescription includes is worth doing before committing to a service, not all providers include the clinical oversight that makes the lifestyle component genuinely supported.
The clinical evidence on tirzepatide's effectiveness covers the weight outcomes in more detail, and our overview of how tirzepatide works explains the mechanism behind appetite suppression. For a broader look at how Mounjaro's effects go beyond the scales, that page draws together what people notice across different areas of daily life. The topic of Mounjaro's effect on hair comes up often too, as another example of the body-wide changes that can accompany rapid weight loss.
Most of the fitness-related changes people attribute to Mounjaro fall into one of three categories: things that genuinely improve (exercise tolerance, joint comfort, breathlessness on stairs), things that temporarily worsen (energy levels, gym capacity), and things that require active management (muscle preservation, protein adequacy, hydration). Knowing which category you are dealing with helps you respond sensibly rather than either pushing through something that warrants caution or abandoning activity that would help.
If fatigue is persistent rather than episodic, or if you experience symptoms that feel unusual (dizziness, significant weakness, chest discomfort during exercise) that is a conversation for your prescribing clinician, not something to manage alone. Mounjaro is a prescription medicine, and the clinical relationship that comes with a legitimate prescription is precisely the resource for these moments.
At nume, a real prescriber reviews every consultation, not software, and that same clinical team is available for aftercare questions seven days a week. The pen itself arrives in plain packaging via DPD with a tracking link, straightforward and discreet. If you'd like to explore whether treatment is right for you, you can speak to our prescribers through a free consultation. Our clinical team is also happy to field questions about what starting treatment realistically involves, including the fitness picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.